Literature DB >> 12078891

Prognostic factors and treatment outcome in patients with primary progressive and relapsed Hodgkin's disease.

A Josting1, A Engert, V Diehl, G P Canellos.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12078891     DOI： 10.1093/annonc/13.s1.112

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  3 in total

1.  Programmed Death-1 Blockade With Pembrolizumab in Patients With Classical Hodgkin Lymphoma After Brentuximab Vedotin Failure.

Authors:  Philippe Armand; Margaret A Shipp; Vincent Ribrag; Jean-Marie Michot; Pier Luigi Zinzani; John Kuruvilla; Ellen S Snyder; Alejandro D Ricart; Arun Balakumaran; Shelonitda Rose; Craig H Moskowitz
Journal:  J Clin Oncol       Date:  2016-11-01       Impact factor: 44.544

2.  Outcome of hematopoietic stem cell transplant as salvage therapy for Hodgkin's lymphoma in adolescents and young adults at a single institution.

Authors:  J A Shafer; H E Heslop; M K Brenner; G Carrum; M F Wu; H Liu; N Ahmed; S Gottschalk; R Kamble; K S Leung; G D Myers; C M Bollard; R A Krance
Journal:  Leuk Lymphoma       Date:  2010-04

3.  Initial response to salvage therapy determines prognosis in relapsed pediatric Hodgkin lymphoma patients.

Authors:  Monika L Metzger; Melissa M Hudson; Matthew J Krasin; Jianrong Wu; Sue C Kaste; Larry E Kun; John T Sandlund; Scott C Howard
Journal:  Cancer       Date:  2010-09-15       Impact factor: 6.860
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.